On 05 March 2014
Dr Reddy's Laboratories announced that it has launched Moxifloxacin Hydrochloride Tablets, 400 mg., a therapeutic equivalent generic version of Avelox (moxifloxacin HCI) tablets 400 mg in the US market on 05 March 2014, subject to approval of United States Food & Drug Administration (USFDA).Powered by Capital Market - Live News
